Welcome to our dedicated page for Aimfinity Investment I SEC filings (Ticker: AIMTF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Aimfinity Investment I's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Aimfinity Investment I's regulatory disclosures and financial reporting.
Aimfinity Investment Corp. I is asking shareholders to approve a charter amendment that would extend its period to complete a business combination to October 28, 2025 and permit the Board, at the Sponsor's request, to approve up to nine additional one-month extensions through July 28, 2026. The company entered into a Merger Agreement with Docter Inc. that contemplates a reincorporation merger into a Cayman Islands PubCo and an acquisition merger resulting in PubCo as the surviving public company.
The proxy explains redemption mechanics: public shareholders may redeem shares for a pro rata cash amount from the Trust Account (including interest) if the Charter Amendment is approved, with attached Class 2 warrants forfeited on redemption. The filing discloses Trust Account funding from the IPO (gross proceeds cited at $80.5 million and $82,110,000 placed in trust) and that an F-4 related to the Docter Business Combination was declared effective by the SEC.
